Stock Research for PFE

Featured Broker: Ally Invest

Get the due diligence for another stock.


PFE Stock Chart & Research Data

The PFE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PFE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PFE Due diligence Resources & Stock Charts

The PFE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PFE Detailed Price Forecast - CNN Money CNN View PFE Detailed Summary - Google Finance
Yahoo View PFE Detailed Summary - Yahoo! Finance Zacks View PFE Stock Research & Analysis -

Stock Analysis

TradeIdeas View PFE Trends & Analysis - Trade-Ideas Barrons View PFE Major Holders - Barrons
NASDAQ View PFE Call Transcripts - NASDAQ Seeking View PFE Breaking News & Analysis - Seeking Alpha
Spotlight View PFE Annual Report - OTC Report View PFE OTC Short Report -
TradeKing View PFE Fundamentals - TradeKing Charts View PFE SEC Filings - Bar Chart
WSJ View Historical Prices for PFE - The WSJ Morningstar View Performance/Total Return for PFE - Morningstar
MarketWatch View the Analyst Estimates for PFE - MarketWatch CNBC View the Earnings History for PFE - CNBC
StockMarketWatch View the PFE Earnings - StockMarketWatch MacroAxis View PFE Buy or Sell Recommendations - MacroAxis
Bullish View the PFE Bullish Patterns - American Bulls Short Pains View PFE Short Pain Metrics -

Social Media Mentions

StockTwits View PFE Stock Mentions - StockTwits PennyStocks View PFE Stock Mentions - PennyStockTweets
Twitter View PFE Stock Mentions - Twitter Invest Hub View PFE Investment Forum News - Investor Hub
Yahoo View PFE Stock Mentions - Yahoo! Message Board Seeking Alpha View PFE Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PFE - Insider Cow View Insider Transactions for PFE - Insider Cow
CNBC View PFE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PFE - OTC Markets
Yahoo View Insider Transactions for PFE - Yahoo! Finance NASDAQ View Institutional Holdings for PFE - NASDAQ

Stock Charts

FinViz View PFE Stock Insight & Charts - StockCharts View PFE Investment Charts -
BarChart View PFE Stock Overview & Charts - BarChart Trading View View PFE User Generated Charts - Trading View

Latest Financial News for PFE

Analysts’ Ratings for Sarepta Therapeutics and Peers in April
Posted on Friday April 20, 2018

How Is Sarepta Therapeutics Positioned in 2018? Sarepta Therapeutics (SRPT) is a commercial stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics, gene therapy, and other genetic approaches for treating rare neuromuscular diseases. Of the 19 analysts covering Sarepta Therapeutics in April 2018, six analysts gave the stock a “strong buy” rating, 11 analysts gave it a “buy” rating, and two analysts gave it a “hold” rating.

P&G's vitamin boost could signal more to come
Posted on Friday April 20, 2018

LONDON/CHICAGO (Reuters) - Procter & Gamble's $4.2 billion deal for Merck's vitamin and supplements business demonstrates that major consumer companies remain hungry for health-related products. The fragmented nature of the sector and its appeal to younger consumers makes further M&A activity a likely prospect even after a spate of recent acquisitions. The U.S.-based maker of Tide detergent and Gillette razors announced its plan on Thursday to buy Merck brands such as Seven Seas vitamins.

J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?
Posted on Friday April 20, 2018

Johnson & Johnson (JNJ) and Novartis reported strong first-quarter 2018 earnings results earlier this week.

Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business
Posted on Friday April 20, 2018

Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.

Enter a stock symbol to view the stock details.